Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia

CONTEXT: Respiratory tract infections (RTI) are common causes of morbidity and mortality worldwide. Initial antibiotic therapy in upper and lower respiratory tract infections is usually empirical. The increasing evidence of antibacterial resistance in the pathogens commonly associated with pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Amitabh, Vindu, Singhal, Anish, Kumar, Sudhir, Patel, Narmada, Rizvi, Yasir S., Mishra, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424864/
https://www.ncbi.nlm.nih.gov/pubmed/22919164
http://dx.doi.org/10.4103/0970-2113.99109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424864/
https://www.ncbi.nlm.nih.gov/pubmed/22919164
http://dx.doi.org/10.4103/0970-2113.99109

Ejemplares similares